Total Payments
$2,269
2024 Payments
$417.76
Companies
10
Transactions
59
Medicare Patients
1,126
Medicare Billing
$215,408
Payment Breakdown by Category
Food & Beverage$2,169 (95.6%)
Education$99.99 (4.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,169 | 58 | 95.6% |
| Education | $99.99 | 1 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $607.45 | 21 | $0 (2024) |
| Alimera Sciences, Inc. | $444.53 | 7 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $367.16 | 5 | $0 (2023) |
| Genentech USA, Inc. | $255.72 | 8 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $165.06 | 4 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $161.21 | 5 | $0 (2024) |
| Allergan Inc. | $99.99 | 1 | $0 (2018) |
| ABBVIE INC. | $91.12 | 4 | $0 (2024) |
| Alcon Vision LLC | $56.32 | 3 | $0 (2022) |
| Spark Therapeutics, Inc. | $20.70 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $417.76 | 20 | Regeneron Healthcare Solutions, Inc. ($138.17) |
| 2023 | $700.80 | 18 | Regeneron Healthcare Solutions, Inc. ($276.76) |
| 2022 | $901.28 | 16 | Alimera Sciences, Inc. ($280.92) |
| 2021 | $106.35 | 2 | Alimera Sciences, Inc. ($85.65) |
| 2019 | $43.08 | 2 | Alcon Vision LLC ($43.08) |
| 2018 | $99.99 | 1 | Allergan Inc. ($99.99) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/31/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/09/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/18/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Ophthalmology | ||||||
| 08/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/28/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/14/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/08/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: EYE CARE | ||||||
| 07/25/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug), VISUDYNE | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Ophthalmology | ||||||
| 07/24/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $28.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/24/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/13/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 05/02/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/25/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Ophthalmology | ||||||
| 04/05/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: EYE CARE | ||||||
| 02/22/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Ophthalmology | ||||||
| 02/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.72 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/14/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/12/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/31/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/24/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/11/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 580 | 773 | $293,449 | $98,372 |
| 2022 | 10 | 345 | 387 | $330,455 | $55,363 |
| 2021 | 6 | 201 | 250 | $320,732 | $61,673 |
Total Patients
1,126
Total Services
1,410
Medicare Billing
$215,408
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 20 | 62 | $101,080 | $42,497 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 130 | 130 | $40,074 | $15,980 | 39.9% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 28 | 28 | $40,862 | $10,430 | 25.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 56 | 92 | $55,119 | $8,370 | 15.2% |
| 92134 | Imaging of retina | Office | 2023 | 195 | 260 | $24,420 | $7,792 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 86 | 108 | $15,622 | $7,344 | 47.0% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 32 | 55 | $8,250 | $3,180 | 38.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 16 | 16 | $4,480 | $1,651 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 17 | 22 | $3,542 | $1,128 | 31.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 19 | 48 | $181,440 | $34,626 | 19.1% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2022 | 31 | 31 | $33,666 | $4,317 | 12.8% |
| 67028 | Injection of drug into eye | Office | 2022 | 46 | 47 | $22,487 | $3,739 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 50 | $25,300 | $3,579 | 14.1% |
| 92134 | Imaging of retina | Office | 2022 | 100 | 102 | $16,116 | $2,599 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 32 | $11,392 | $2,060 | 18.1% |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | Facility | 2022 | 15 | 15 | $17,283 | $1,632 | 9.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $11,844 | $1,368 | 11.6% |
| J3590 | Unclassified biologics | Office | 2022 | 21 | 28 | $7,679 | $999.84 | 13.0% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2022 | 16 | 16 | $3,248 | $442.12 | 13.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 29 | 68 | $257,040 | $49,907 | 19.4% |
| 67028 | Injection of drug into eye | Office | 2021 | 38 | 43 | $20,063 | $3,880 | 19.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 78 | 83 | $13,015 | $2,548 | 19.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 30 | 30 | $10,680 | $2,136 | 20.0% |
| 67042 | Removal of membrane from the retina, pars plana approach with removal of internal limiting membrane of retina | Facility | 2021 | 14 | 14 | $13,862 | $1,987 | 14.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 12 | $6,072 | $1,214 | 20.0% |
About Dr. Eric Williams, M.D
Dr. Eric Williams, M.D is a Ophthalmology healthcare provider based in Blue Ash, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2017. The National Provider Identifier (NPI) number assigned to this provider is 1205367182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Williams, M.D has received a total of $2,269 in payments from pharmaceutical and medical device companies, with $417.76 received in 2024. These payments were reported across 59 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,169).
As a Medicare-enrolled provider, Williams has provided services to 1,126 Medicare beneficiaries, totaling 1,410 services with total Medicare billing of $215,408. Data is available for 3 years (2021–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Student in an Organized Health Care Education/Training Program, Ophthalmology
- Location Blue Ash, OH
- Active Since 03/23/2017
- Last Updated 06/07/2021
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1205367182
Products in Payments
- YUTIQ (Drug) $445.12
- EYLEA (Biological) $430.91
- ILUVIEN (Drug) $366.57
- Vabysmo (Drug) $255.72
- EYLEA HD (Biological) $176.54
- XIPERE (Drug) $165.06
- OZURDEX (Drug) $91.12
- Syfovre (Drug) $55.01
- Centurion (Device) $22.10
- AcrySof (Device) $20.98
- Constellation (Device) $13.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Blue Ash
Dr. Lucas Lindsell, M.d., O.d, M.D., O.D
Ophthalmology — Payments: $89,267
Ophthalmology $89,267
Arjun Sood, Md, MD
Ophthalmology — Payments: $76,589
Ophthalmology $76,589
James Osher, M.d, M.D
Ophthalmology — Payments: $11,589
Ophthalmology $11,589
Ferdinand Rodriguez Agramonte, M.d, M.D
Ophthalmology — Payments: $6,563
Ophthalmology $6,563
Dr. Andrew Barfell, Md, MD
Ophthalmology — Payments: $4,801
Ophthalmology $4,801
Dr. Kavitha Sivaraman, M.d, M.D
Ophthalmology — Payments: $4,612
Ophthalmology $4,612